143 results
8-K
EX-10.1
VXRT
Vaxart Inc
13 Jun 24
Departure of Directors or Certain Officers
4:07pm
) or posted on the Company’s intranet (or other shared electronic medium controlled by the Company to which the Participant has access).
(j) Deferrals
8-K
EX-10.1
3odu16jd534ywdaext
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
424B5
b2h1zfa zfii
17 Jan 24
Prospectus supplement for primary offering
7:18pm
8-K
EX-10.1
cnsiqo83nm2cag8m9138
16 Jan 24
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
5:18pm
8-K
EX-3.1
g3f2zusenwu1r9
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
EX-1.1
042clp qjzwbd
8 Jun 23
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
4:27pm
424B5
0nq5ehqdzqbqvzj
8 Jun 23
Prospectus supplement for primary offering
4:17pm
424B5
ej2bdy8tr0
6 Jun 23
Prospectus supplement for primary offering
5:21pm
424B5
bjesl3a73d1 3kr
9 May 23
Prospectus supplement for primary offering
2:41pm
8-K
EX-99.1
rm134vcxm7
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm